Article Versions Notes

Grubovikj RM, Alavi A, Koppel A, Territo M, Schiller GJ. Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission. Cancers. 2012; 4(2):601-617. https://doi.org/10.3390/cancers4020601

Grubovikj, Rada M., Asif Alavi, Ahrin Koppel, Mary Territo, and Gary J. Schiller. 2012. "Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission" Cancers 4, no. 2: 601-617. https://doi.org/10.3390/cancers4020601

Grubovikj, R. M., Alavi, A., Koppel, A., Territo, M., & Schiller, G. J. (2012). Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission. Cancers, 4(2), 601-617. https://doi.org/10.3390/cancers4020601